Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-25

Clinical Trial Update: Aprepitant Treatment to Prevent Postoperative Nausea and Vomiting in Children Undergoing Scoliosis Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating aprepitant to prevent postoperative nausea and vomiting in children undergoing scoliosis (spinal fusion) surgery; recruitment is o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aprepitant (aprepitant)

Snippet

Sponsor: IWK Health Centre | Conditions: Spinal Fusion, Nausea and Vomiting, Postoperative | Phase 2 | Status: RECRUITING